Umbralisib/TGR-1202 as a Novel Dual PI3K/CK1 Inhibitor Has a Unique Therapeutic Role in Silencing Oncogenes in Aggressive Lymphomas

Drug Category : Array
Conference Category : Array
Lead Author : O'Connor, et al.
Published Date : 10/12/2017
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/ASH%202017%20Ipsita%20Final.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top